Issued Patents All Time
Showing 1–25 of 71 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9896444 | Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 | Pascal Furet, Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones, Andreas Marzinzik +3 more | 2018-02-20 |
| 9458112 | Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 | Pascal Furet, Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones, Andreas Marzinzik +4 more | 2016-10-04 |
| 9340537 | Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 | Pascal Furet, Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones, Andreas Marzinzik +3 more | 2016-05-17 |
| 9315489 | Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 | Pascal Furet, Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones, Andreas Marzinzik +4 more | 2016-04-19 |
| 9278981 | Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 | Pascal Furet, Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones, Andreas Marzinzik +4 more | 2016-03-08 |
| 9163005 | Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide | Wen-Chung Shieh, Paul Allen Sutton, Piotr H. Karpinski, Raeann Wu, Stéphanie Monnier +1 more | 2015-10-20 |
| 8829195 | Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 | Stephanie Kay Dodd, Pascal Furet, Robert M. Grotzfeld, Wolfgang Jahnke, Darryl Brynley Jones +4 more | 2014-09-09 |
| 8829015 | Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide | Wen-Chung Shieh, Paul Allen Sutton, Piotr Karpinski, Raeann Wu, Stéphanie Monnier +1 more | 2014-09-09 |
| 8673930 | Pyrimidylaminobenzamide derivatives for systemic mastocytosis | Leila Alland, Doriano Fabbro, Jurgen Mestan | 2014-03-18 |
| 8653093 | Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases | Leila Alland, Juergen Mestan | 2014-02-18 |
| 8604045 | Pyrimidylaminobenzamide derivatives for treatment of neurofibromatosis | — | 2013-12-10 |
| 8580806 | Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide | Wen-Chung Shieh, Paul Allen Sutton, Piotr H. Karpinski, Raeann Wu, Stéphanie Monnier +1 more | 2013-11-12 |
| 8552002 | Compounds and compositions as protein kinase inhibitors | Qiang Ding, Nathanael S. Gray, Bing Li, Yi Liu, Taebo Sim +11 more | 2013-10-08 |
| 8513256 | Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide | Hans Michael Bürger, Michael Mutz | 2013-08-20 |
| 8445479 | Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity | James Douglas Griffin | 2013-05-21 |
| 8415363 | Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide | Wen-Chung Shieh, Paul Allen Sutton, Piotr Karpinski, Raeann Wu, Stéphanie Monnier +1 more | 2013-04-09 |
| 8389537 | Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide | Wen-Chung Shieh, Paul Allen Sutton, Piotr H. Karpinski, Raeann Wu, Stéphanie Monnier +1 more | 2013-03-05 |
| 8343984 | Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide | Wen-Chung Shieh, Paul Allen Sutton, Piotr Karpinski, Raeann Wu, Stéphanie Monnier +1 more | 2013-01-01 |
| 8268837 | Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia | Nicholas J. Donato, Doriano Fabbro, Jurgen Mestan, Markus Warmuth, Michael Hallek +2 more | 2012-09-18 |
| 8222244 | Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity | James Douglas Griffin | 2012-07-17 |
| 8217045 | Organic compounds | Joseph Schoepfer | 2012-07-10 |
| 8163904 | Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-Benzamide | Wen-Chung Shieh, Paul Allen Sutton, Piotr H. Karpinski, Raeann Wu, Stéphanie Monnier +1 more | 2012-04-24 |
| 8133886 | Heterobicyclic carboxamides as inhibitors for kinases | Guido Bold, Andrea Vaupel, Carole Pissot Soldermann | 2012-03-13 |
| 8119649 | Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia | Nicholas J. Donato, Doriano Fabbro, Jurgen Mestan, Markus Warmuth, Michael Hallek +2 more | 2012-02-21 |
| 8093259 | 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]-benzamide for treatment of melanoma | Georg Martiny-Baron, Juergen Mestan | 2012-01-10 |